Fulcrum Therapeutics (FULC) Receivables - Net (2020 - 2022)

Fulcrum Therapeutics (FULC) has 3 years of Receivables - Net data on file, last reported at $13000.0 in Q3 2022.

• Receivables - Net for Q3 2022 came in at $13000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was $13000.0 (changed N/A YoY), and the FY2021 annual result was $2.5 million, up 25.0% from the prior year.
• Receivables - Net retreated to $13000.0 in Q3 2022 per FULC's latest filing, from $357000.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $2.5 million in Q4 2021 and troughed at $13000.0 in Q3 2022.
• A 3-year average of $1.2 million and a median of $1.2 million in 2020 frame the typical range for Receivables - Net.
• On a YoY basis, Receivables - Net climbed as much as 25.0% in 2021 and fell as far as 25.0% in 2021.
• A 3-year view of Receivables - Net shows it stood at $2.0 million in 2020, then advanced by 25.0% to $2.5 million in 2021, then sank by 99.48% to $13000.0 in 2022.
• Business Quant data shows FULC's Receivables - Net at $13000.0 in Q3 2022, $357000.0 in Q2 2022, and $2.5 million in Q4 2021.